Toxoplasma Gondii-associated Guillain-Barré Syndrome in an Immunocompetent Patient

Overview

Journal J Clin Microbiol

Specialty Microbiology

Date 1998 Nov 18

PMID 9817908

Citations 12

Authors

P Bossi

E Caumes

L Paris

M L Darde

F Bricaire

Affiliations

Soon will be listed here.

Abstract

We report a case of Guillain-Barré syndrome associated with an acute, disseminated toxoplasmosis due to a new and unknown zymodeme (zymodeme 12) in an immunocompetent patient. The patient's condition improved with pyrimethamine and sulfadiazine. Only the standard treatment for toxoplasmosis was effective, whereas intravenous immunoglobulins were ineffective.

Citing Articles

Antibody Responses to EBV and Toxoplasma and Their Genetic Links to Guillain-Barré Syndrome: A Mendelian Randomization Study.

Qi X, Gao L, Qi L Brain Behav. 2025; 15(2):e70298.

PMID: 39924945 PMC: 11808176. DOI: 10.1002/brb3.70298.

Clinical Spectrum, Radiological Findings, and Outcomes of Severe Toxoplasmosis in Immunocompetent Hosts: A Systematic Review.

Layton J, Theiopoulou D, Rutenberg D, Elshereye A, Zhang Y, Sinnott J Pathogens. 2023; 12(4).

PMID: 37111429 PMC: 10145896. DOI: 10.3390/pathogens12040543.

Toxoplasma gondii in South America: a differentiated pattern of spread, population structure and clinical manifestations.

de Lima Bessa G, Vitor R, Dos Santos Martins-Duarte E Parasitol Res. 2021; 120(9):3065-3076.

PMID: 34390383 DOI: 10.1007/s00436-021-07282-w.

Molecular mechanism for the control of virulent Toxoplasma gondii infections in wild-derived mice.

Murillo-Leon M, Muller U, Zimmermann I, Singh S, Widdershooven P, Campos C Nat Commun. 2019; 10(1):1233.

PMID: 30874554 PMC: 6420625. DOI: 10.1038/s41467-019-09200-2.

Investigation of the Role of Campylobacter Infection in Suspected Acute Polyradiculoneuritis in Dogs.

Martinez-Anton L, Marenda M, Firestone S, Bushell R, Child G, Hamilton A J Vet Intern Med. 2018; 32(1):352-360.

PMID: 29356096 PMC: 5787210. DOI: 10.1111/jvim.15030.

References

DANO P, Le Guyader J, Caron R . [Acute polyradiculoneuritis and toxoplasmosis]. Rev Neurol (Paris). 1985; 141(11):743-5. View

Rostami A . Guillain-Barré syndrome: clinical and immunological aspects. Springer Semin Immunopathol. 1995; 17(1):29-42. DOI: 10.1007/BF00194098. View

Salisbury D . Association between oral poliovaccine and Guillain-Barré syndrome?. Lancet. 1998; 351(9096):79-80. DOI: 10.1016/s0140-6736(05)78156-3. View

Darde M, Villena I, Pinon J, Beguinot I . Severe toxoplasmosis caused by a Toxoplasma gondii strain with a new isoenzyme type acquired in French Guyana. J Clin Microbiol. 1998; 36(1):324. PMC: 124868. DOI: 10.1128/JCM.36.1.324-324.1998. View

Hughes R, Rees J . Clinical and epidemiologic features of Guillain-Barré syndrome. J Infect Dis. 1997; 176 Suppl 2:S92-8. DOI: 10.1086/513793. View